@ARTICLE{
author={Afzali Anita,Panes Julian,Sands Bruce E,Rubin David T,Panaccione Remo,Terry Natalie A,Salese Leonardo,Van Rampelbergh Rian,Yang Zijiang,Frustaci Mary Ellen,Tarabar Dino K,Chen Minhu,Mihaly Emese,Wolf Douglas,D'Haens Geert R},
year={2024},
title={Efficacy of Guselkumab in Moderately to Severely Active Crohn's Disease According to Induction Clinical Response Status: Week 48 Results from the GALAXI 2 & 3 Phase 3 Trials},
journal={AMERICAN JOURNAL OF GASTROENTEROLOGY},
volume={119},
number={10S},
pages={S1024-S1025},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tarabar Dino K,El Jurdi Katia,Traboulsi Cindy,Yvellez Olivia,Milenkovic Zoran,Petrovic Stanko S,Subotic Bojana N,Gils Ann,Brocic Tanja P,Brcerevic Irina A,Latinovic Olgica,Jocic Tanja,Rubin David T},
year={2022},
title={A Prospective Trial with Long Term Follow-up of Patients With Severe, Steroid-Resistant Ulcerative Colitis Who Received Induction Therapy With Cyclosporine and Were Maintained With Vedolizumab},
journal={INFLAMMATORY BOWEL DISEASES},
volume={28},
number={10},
pages={1549-1554},
document_type={Article},
} 

@ARTICLE{
author={Danese Silvio,Colombel J-F,Ponich T,Jovanovic Igor,Bossuyt Peter,Longman R,Alekseeva O,Petersen AK,Marta C,Charles Lorna,Sparrow M,Rubin David T,Afzali A,Loftus EV Jr,Wolf DC},
year={2022},
title={Long-term use of ozanimod in patients with moderately to severely active ulcerative colitis},
journal={JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY},
volume={37},
number={},
pages={125-126},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Danese Silvio,Colombel J-F,Ponich T,Jovanovic Igor,Bossuyt Peter,Longman R,Alekseeva O,Petersen AK,Chitkara Denesh,Marta C,Charles Lorna,Rubin David T,Afzali A,Loftus EV Jr,Wolf DC},
year={2022},
title={Long-term use of ozanimod in patients with moderately to severely active Ulcerative Colitis},
journal={JOURNAL OF CROHNS & COLITIS},
volume={16},
number={},
pages={I093-I094},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tarabar Dino K,El Jurdi Katia,Yvellez Olivia,Milenkovic Zoran,Petrovic Stanko S,Subotic Bojana N,Brocic Tanja P,Brcerevic Irina A,Latinovic Olgica,Rubin David T},
year={2018},
title={Combination therapy of cyclosporine and vedolizumab is effective and safe for severe, steroid-resistant ulcerative colitis patients: A prospective study},
journal={JOURNAL OF CROHNS & COLITIS},
volume={12},
number={},
pages={S65-S65},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tarabar Dino K,Hirsch Ayal,Rubin David T},
year={2016},
title={Vedolizumab in the treatment of Crohn's disease},
journal={EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY},
volume={10},
number={3},
pages={283-290},
document_type={Article},
} 

@ARTICLE{
author={Rubin David T,Randall Charles,Coarse Jason,Kosutic Gordana,Spearman Marshall,Ambarkhane Sumeet,Jojic Njegica Z},
year={2014},
title={Crohn's Disease Behavior as a Risk Factor for Loss of Maintenance of Remission in Patients Treated With Certolizumab Pegol: Results From the PRECiSE 3 Study},
journal={AMERICAN JOURNAL OF GASTROENTEROLOGY},
volume={109},
number={},
pages={S508-S509},
document_type={Meeting Abstract},
}